Facial Hyperpigmentation: A Rare Side Effect of Adalimumab

• Autors principals: Malek Mrad MD (Autor), Mariam Tabka MD (Autor), Asmahane Souissi MD (Autor), Ines Chelly MD (Autor), Mourad Mokni MD (Autor)
• Format: Llibre
• Publicat: SAGE Publishing, 2024-07-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

This report describes a case of facial hyperpigmentation in a patient with Crohn's disease receiving adalimumab, a tumor necrosis factor (TNF)-alpha inhibitor. The onset of hyperpigmentation coincided with adalimumab administration, and its discontinuation resulted in significant improvement. H...